Abstract
A patient is described in whom fatal myopathy occurred, and its cause appears to be the consequence of simvastatin therapy. © 2007 Elsevier Inc. All rights reserved. (Am J Cardiol 2007;99:1171-1176).
Cite
CITATION STYLE
APA
Boltan, D. D., Lachar, W., Khetan, A., Bouffard, J. P., & Roberts, W. C. (2023). Fatal and widespread skeletal myopathy confirmed morphologically years after initiation of simvastatin therapy. In Case Reports in Cardiology: Coronary Heart Disease and Hyperlipidemia (pp. 246–253). CRC Press. https://doi.org/10.1201/9781003409335-43
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free